Endocrinologists who scored highest on the American Board of Internal Medicine's Longitudinal Knowledge Assessment (LKA) were ...

Benjamin Lee explains why changing body composition is more than weight loss, with a focus on lean muscle, metabolic health ...

This is the Fall 2026 Membership Meeting of the Forum on Neuroscience and Nervous System Disorders. Members will receive an ...

Approval based on AZUR-1 data showing clinically significant proportion of participants with no detectable signs of cancer one year or more after treatment No disease recurrences reported ...

Diabetes is a chronic condition involving issues regulating blood sugar (glucose). When glucose levels are too high, you may be at risk of developing problems with your kidneys, heart, and other parts ...

Newswise — Wastewater reclamation is increasingly important as water scarcity intensifies worldwide. Advanced treatments such as ozonation, UV irradiation, and biological activated carbon filtration ...

Additionally, long-term durable outcomes with Olumiant (baricitinib) in pediatric patients 12 years of age and older with severe alopecia areata will be presented from the BRAVE-AA-PEDS clinical trial ...

Final 2025 CDC data show a record-low U.S. fertility rate of 53.2 and a 7% drop in teen births. What the numbers mean for maternity care access. Ric Flair Hospitalized Following Tampa Fall Hours After ...

What Is Ibrance, and Why Does It Matter? Ibrance (palbociclib) is a targeted cancer pill for treating certain forms of breast cancer. The FDA has now approved its use combined with other targeted anti ...

New giredestrant data from the lidERA study on its potential as a new standard of care for adjuvant ER-positive breast cancer across all menopausal stages Overall, nine approved and investigational ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Timing of PIK3CA Mutation Testing in HR-Positive Metastatic Breast Cancer: Upfront vs. at Progression Heather McArthur, MD, Komen Distinguished Chair in Clinical Breast Cancer Research at UT ...